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Aims: In the ovary, endothelins regulate a variety of ovarian functions that include but not limited to
folliculogenesis, steroidogenesis, oocyte maturation, ovulation and corpus luteum (CL) function. Two cognate
receptors, EDNRA and EDNRB are constitutively expressed in the ovary, andmediate the regulatory endothelin
actions. However, the physiological signiﬁcance of the presence of the two receptors that often elicit opposite
responses upon activation by an endothelin is yet to be determined. This study was proposed to test the
hypothesis that both receptors are present in the ovary to lend an endothelin a ﬁnite regulation of ovulation.
Main methods: A rescued EDNRB knockout (rEDNRB-KO) mouse that is deﬁcient of EDNRB expression in all
cells but adrenergic cell lineage was used to test the impact of the loss of function of EDNRB on ovulation.
The EDNRB gene deletion and its conﬁrmation at mRNA level were assessed by molecular biology techniques,
and the number and size of corpus lutea was determined by ovarian histology.
Key ﬁndings: Female rEDNRB-KO mice had larger litter sizes (numbers of pups per birth) and their ovaries
contained more corpora lutea than wild type littermates.
Signiﬁcance: This result shows that without EDNRB excessive ovulation occurs, suggesting a role of EDNRB in
having the extent of ovulation conﬁned.© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Endothelin (EDN) actions are mediated by G protein-coupled
receptors, termed endothelin receptor type A (EDNRA) and type B
(EDNRB) that have different molecular and pharmacological
characteristics: EDNRA has a higher afﬁnity to EDN1 and EDN2 than to
END3, and induces prolonged vasoconstriction when activated (Arai
et al., 1990; Flores et al., 1995; Gentili et al., 2001; Kedzierski and
Yanagisawa, 2001; Mamluk et al., 1999b; Mancina et al., 1997;
Meidan and Levy, 2002). EDNRB, on the other hand, binds to all three
endothelins with equipotent afﬁnity and induces vasodilation upon ac-
tivation (Mamluk et al., 1999a). Upon agonist binding, both receptors
are rapidly internalized via a common pathway from early endosomes
to the lysosomes (Mamluk et al., 1998b). However, they are subse-
quently targeted to different intracellular localizations (Mamluk et al.,
1998b): whereas the EDNRA follows the recycling pathway, reappear-
ing at the plasmamembrane, EDNRB is directed to lysosomes for degra-
dation (Mamluk et al., 1998a). The rapid recycling of the EDNRA elicitsrative Biosciences, College of
mpaign, 3806 VMBSB, MC-002,
1 217 333 9362; fax: +1 217
-NC-ND license.sustained signaling response (Mamluk et al., 1998a). Conversely, lyso-
somal targeting of the EDNRB is consistent with its role in the clearance
of endothelin from the circulation (Diamantis et al., 1998). In the ovary,
both receptors are expressed and are presumed to mediate endothelin
actions in regulating a variety of ovarian functions that include folliculo-
genesis, steroidogenesis, oocyte maturation, ovulation and corpus
luteum (CL) function (Gentili et al., 2001; Meidan and Levy, 2002;
Schneider et al., 2007). However, the physiological signiﬁcance of hav-
ing the two receptors co-expressed in the ovary is yet to be determined
(Bridges et al., 2010a; Girsh et al., 1996b; Hinckley and Milvae, 2001;
Levy et al., 2001; Meidan et al., 1999; Ohtani et al., 1998; Palanisamy
et al., 2006). As EDNRA and EDNRB elicit mostly opposite physiological
responses in an affected tissue, we hypothesized that activation of both
receptors is required for a ﬁnely tuned regulation of endothelin action
in regulating ovarian function. This hypothesis implicates that when
the proposed ‘ﬁne tuning’ of endothelin action is lost, an extreme phys-
iological outcome may ensure, leading to hyper-stimulation or hypo-
stimulation of a physiological event. For example, ovulation may con-
tinue when this event needs to be terminated or CL persists when this
tissue needs to be demised. This study was designed to test the speciﬁc
hypothesis that both receptors are present in the ovary to lend an
endothelin a ﬁnite regulation of ovulation.
Genetically modiﬁed animal models such as knockout mice would
provide an ideal experimental condition for testing the hypothesis.
614 J. Cho et al. / Life Sciences 91 (2012) 613–617However, both EDNRA and EDNRB knockout (KO)mice do not survive
to the sexual maturation due to defects in neural crest development
and aganglionic megacolon, respectively (Clouthier et al., 1998;
Hosoda et al., 1994), making them unavailable for determining func-
tional roles of the receptors in regulating ovulation. As an alternative,
we used a rescued EDNRB KO (rEDNRB-KO) mouse line that is
deﬁcient of EDNRB expression in all cells but adrenergic cell lineage
in this study to test the hypothesis. The rEDNRB-KO mouse has a
null mutation in the EDNRB gene, but survives to adulthood due to
a transgenic expression of EDNRB driven by human dopamine-β-
hydroxylase (DβH) promoter (Hosoda et al., 1994; Murakoshi et al.,
2002; Quaschning et al., 2005). Here, we show that rEDNRB-KO mice
displayed higher fecundity and their ovaries contained excessively
larger numbers of CL.
Materials and methods
Animals
The rEDNRB-KO mice were produced by successively breeding
heterozygous EDNRB knockout mice (EDNRB+/-) with human DβH
gene promoter-regulated EDNRB receptor transgenic mice (DβH-
EDNRB) as previously described (Murakoshi et al., 2002; Quaschning
et al., 2005). Three resulting genotypes that included WT mice
(EDNRB+/+), heterozygous EDNRB-KO (EDNRB+/-) and rescued
EDNRB-KO mice (EDNRB-/-·DβH-EDNRB) were used in this study.
Fertility was determined by counting the number of pups per litter of
2–6 month old WT, EDNRB+/- and rEDNRB-KO female mice. All animal
experiment procedures were reviewed and approved by the Institu-
tional Animal Care and Research Advisory Committee of the University
of Texas Southwestern Medical Center.
Genomic PCR and RT-PCR of EDNRB
To verify the deletion of EDNRB gene in the ovaries of rEDNRB-KO
mice, genomic DNA isolated from the ovaries of rEDNRB-KO and WT
mice were analyzed by polymerase chain reaction (PCR) (Murakoshi
et al., 2002). Presence of the endogenous EDNRB gene in the WT
mice and the transgenic EDNRB sequence in the rEDNRB-KO mice
were conﬁrmed using primer sets that bind to exon 2 (P3; 5′-TTG
CTC GCA GAG GAC TGG CCA-3′) and exon 3 (P4; 5′-AAG CAT GCA
GAC CCT TAG GGG-3′) to differentiate the WT and rEDNRB-KO mice
(Fig. 1A). In rEDNRB-KOmice, the introduced cDNA fragment detected
by these primers does not include introns (298 bp) and thereforeA WT
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Fig. 1. rEDNRB-KO mouse ovary is deﬁcient of ENDRB gene and mRNA expression. A, Sch
rEDNRB-KO mouse, exon 3 is replaced with Neo cassette and the genome has a transgenic
sence of exon 3 in the rEDNRB-KO ovarian genomic DNA. Genomic DNA isolated from rEDN
bination yields 298 bp product from rEDNRB-KO transgenic construct, whereas 410 bp pr
product from rEDNRB-KO genome, but no product from WT genome. C, Detection of ED
EDNRB bands are shown in WT but not rEDNRB-KO ovaries. Two mice for each genotype wcan be distinguished from the WT fragment which has a larger size
(420 bp) due to the introns. In addition, the deletion of the EDNRB
gene in the ovary of rEDNRB-KO mice was conﬁrmed by PCR using
primer sets that bind to the neomycin-resistant gene (P1; 5′-GGA
TGC GGT GGG CTC TAT GGC TTC TGA-3′) and exon 4 (P2; 5′-ATC
TGC ATA CCG CTC TTC TTC CTG AGC ATT TC-3′). The presence of a
PCR product with the P1+P2 primer set was interpreted as the
evidence of the deletion of exon 3 of the EDNRB gene while a 420 bp
PCR product with the P3+P4 primer set was considered proof of the
presence of the wild type EDNRB gene.
For conﬁrmation of ENDRB deletion in the rEDNRB-KO mice at
mRNA levels, total RNA was also isolated from WT and rEDNRB-KO
mice ovaries using Trizol (Invitrogen) and RNeasy kit (QIAGEN Inc.,
Valencia, CA). A DNase1 reaction buffer (Invitrogen), DNase1
(Invitrogen) and 25 mM EDTA (Invitrogen) were added to total RNA
(1 μg) in 15.5 μl before heating at 65 C for 15 min, then heated at
72 C for 10 min after mixing the 12.5 μl of total RNA mixture and 1 μl
oligo dT (Invitrogen). Then a cocktail of 5×1st strand buffer, 10 mM
dNTP, 40 IU RNase out, and 200 IU Moloney leukemia virus reverse
transcriptase were added to a total volume of 20 μl. The reaction mix-
ture was incubated at 42 C for 60 min then heated at 94 C for 5 min to
inactivate RNase H. And then 100 μl of DEPC H2O was added to the
mixture. One microlitter cDNA was added to the 10 μl PCR mixture
containing 1 × PCR buffer, 1.5 mMMgCl2, 0.2 mMdNTP, 0.2 μMprimer
sets that bind to exon 2 (P3) and exon 3 (P4), and TaqDNApolymerase
(0.5 IU) and ampliﬁed with 34 cycles. The RT-PCR products were
separated on a 1.2% agarose gel, stained with ethidium bromide, and
scanned on a phosphor imager (FujiFilm FLA-5000).Ovarian histology
Ovaries of rEDNRB-KO (n=5) and WT (n=4) mice at the ages of
6 weeks were collected and ﬁxed in 4% paraformaldehyde. Tissues
were then embedded in parafﬁn blocks, serially sectioned at 7 μm,
and every 10th of serial sections were stained with hematoxylin
and eosin (H&E) following a routine staining procedure (Al-Alem
et al., 2007, Lee et al., 2009). The number of corpora lutea (CL) were
counted microscopically using a BX51 microscope (Olympus, Tokyo,
Japan) equipped with a digital camera (DP 70; Olympus, Tokyo,
Japan). The sizes of CL were calculated by measuring the longest
diameter of each CL under the assumption that a CL would have a
spherical structure. The following equation was used to estimate the
volume of the CL: volume (nl)=4/3×r (radius, um)3×π.rEDNRB-KO
(EDNRB-/-; DβH-EDNRB)
neo 
Exon
4 
Exon
2 
P1 P2
P3 P4
DβH-Promoter Exon1 
Exon
2 
Exon
3 
Exon
4 
 298bp
 200bp
    #1         #2    #1        #2      water 
rEDNRB-KO WT   Ctrl 
3+P4
L19
ematic diagram of EDNRB genomic structure of the WT and rEDNRB-KO mice. In the
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Fig. 2. rEDNRB-KO mice are hyper-fecund. Female mice from the 3 different genotypes
at the ages of 3–6 months were individually housed with proven males for the period
of 2–5 months. During the breeding periods, the numbers of litters and pups were
counted. Note that rEDNRB-KO mice gave births to largest numbers of pups per litter.
The p values and number (n) of animals used are shown.
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Statistical signiﬁcances were assessed using Mann–Whitney rank
sum test for numbers of CL and numbers of pups per litter. For all sta-
tistical analysis, Pb0.05 was considered signiﬁcant.
Results
rEDNRB-KO ovary is deﬁcient of EDNRB mRNA expression
A rEDNRB-KO mouse has two independent genetic modiﬁcations.
First, this mouse is deﬁcient of EDNRB expression due to the re-
placement of the exon 3 of the EDNRB gene with a Neo cassette
(Murakoshi et al., 2002). Second, it has a transgenic insertion of a
human DβH promoter-EDNRB cDNA that expresses functionalrEDNRB-KO 
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Fig. 3. rEDNRB-KO mouse ovary had more numbers of corpora lutea. Ovaries were collecte
were counted micrscopically. A, Representative sectional image of WT and rEDNRB-KO o
rEDNRB-KO than WT ovaries. The p values and number (n) of animals used are shown.EDNRB in the adrenergic lineage cells (Murakoshi et al., 2002).
Absence of exon 3 but the presence of exogenous EDNRB cDNA
sequence was veriﬁed by PCR with genomic DNA extracted from
rEDNRB-KO mouse ovaries (Fig. 1A–B). Deﬁciency of EDNRB mRNA
expression in the rEDNRB-KO mouse ovary was conﬁrmed by
performing RT-PCR, which produced expected cDNA bands in the
WT ovaries, but not in the rEDNRB-KO ovary (Fig. 1C).
rEDNRB-KO female mice are hyper-fecund
As a way to assess the overall signiﬁcance of EDNRB expression in
the ovary, fecundity of the rEDNRB-KO mice was ﬁrst compared with
that of the rEDNRB+/- (globally heterozygous for EDNRB gene) and
rEDNRB+/+ (wild type) littermates by retrospectively counting the
numbers of litters and the litter sizes per mouse. Surprisingly, rather
than showing a fertility defect, rEDNRB-KO mice displayed a higher
fecundity over control mice as rEDNRB litter sizes (7.9±0.73 pups/
litter) were signiﬁcantly larger than EDNRB+/- (6.19±0.24 pups/
litter) and WT (5.47±0.11 pups/litter) (Fig. 2). No difference was
however seen in the number of litters per mouse in any of the 3
genotypes compared (data not shown).
Ovaries of rEDNRB-KO mice have bigger and more corpora lutea than
wild type mice
To determine whether the unexpectedly higher fecundity of
rEDNRB-KO mice was an outcome of increased ovulation due to the
loss of EDNRB, the numbers of the CL of these mice were counted
and compared to those of WT mice. CLs were used as markers of
ovulation as a CL will be formed from a successfully ovulated follicle.
For this purpose, ovaries of 6-week old rEDNRB-KO and WT mice
were serially sectioned and the total numbers of CL were counted.
The data showed that the ovaries of rEDNRB-KO contained signiﬁ-
cantly larger numbers of CL (17.8±2.2/ovary) than those of WT
mice (8.75±0.48/ovary) (Fig. 3.). Interestingly, the mean diameter
of rEDNRB-KO CL was wider (389.52±12.22 μm) than that of WT
(310.14±18.18 μm) (Fig. 4A). This much of a difference in diameter
would be equal to a 1.82 fold difference in CL volume (39 vs. 21
pico litter) (Fig. 4B.).WT rEDNRB-KO 
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Fig. 4. rEDNRB-KO mouse ovary has larger corpus lutea. Ovaries were collected at the
ages of 10–11 weeks, subjected to histological analysis and the diameter of corpora
lutea were measured microscopically in the ovaries of 5 rEDNRB-KO (n=5) and 4
WT mice (n=4). A, Diameter of corpus lutea of the rEDNRB-KO and WT ovaries.
B, Diameter of corpus lutea of the rEDNRB-KO and WT ovaries. Note that while
rEDNRB-KO ovaries are 1.26 times larger in diameter, they are 1.82 times bigger in
their volume compared to WT ovaries. The p values and number (n) of CL examined
are shown.
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This study was an attempt to gain insight into the signiﬁcance of
expressing both receptors in the ovary in regulating each of the
ovarian functions. In the ovary, most of physiological events occur
sequentially and cyclically: follicles grow and rupture, hormone levels
rise and fall, oocyte maturation begins and stops and CL are formed
and regress. These phenomena implicate that there must be drivers
that either initiate or accelerate the processes and stoppers that
may attenuate and terminate the biological events. The most exten-
sively studied role of endothelin system as contraction regulator in
vasculature ﬁts well with this logic as EDN1 triggers constriction via
EDNRA (Kedzierski and Yanagisawa, 2001; Luscher and Barton,
2000), whereas EDNRB facilitates the clearance of endothelin
(Diamantis et al., 1998). Therefore, it was hypothesized that having
both receptors present in the ovary may lend an endothelin a ﬁnite
regulation of the ovarian events, including ovulation, EDNRA as a trig-
ger of ovulation and EDNRB as a terminator of ovulation. This hypoth-
esis presumes that loss of EDNRB would results in faulty termination
of the endothelin-regulated biological events. In this study, ovulation
was chosen as a model subject for testing the hypothesis because we
have expertise in studying ovulation.
The proven fertility of the rEDNRB-KO mice clearly demonstrates
that EDNRB is not required for ovulation to occur, but the increased
fecundity and larger CL numbers in the rEDNRB-KO mice (Figs. 2–4)
show that EDNRB is necessary for limiting ovulation. While being
speculative, the more CL and higher fecundity (larger litter size)
seen in the rEDNRB-KO mice indicate that EDNRB may play an anti-
ovulatory role and therefore ovulation rate may increase when the
antagonism is compromised. Presently, the nature of antagonism is
not known. However, one can speculate that EDNRB may ‘actively’
antagonize the EDNRA-driven ovulatory events (Bridges et al.,
2010b; Ko et al., 2006) as a scavenger of endothelins as is in circula-
tion system (Diamantis et al., 1998). Without EDNRB, the EDNRA-
driven ovulatory events could be stronger and may last longer, result-
ing in ovulating follicles that would not otherwise be.
Meanwhile, EDNRB is not required for ovulation in rats as rescued
EDNRB-KO rats are fertile (Gariepy et al., 1998). Successful ovulation
of the rEDNRB-KO mice (this study) and rats (Gariepy et al., 1998)
leaves EDNRA as the endothelin receptor that drives ovulation. This
may be true as we recently showed that EDNRA is responsible forEDN2-induced ovarian constriction (Bridges et al., 2010a) that is
shown to play critical role in ovulation (Bridges et al., 2010b; Ko
et al., 2006).
The antagonismmay continue during CL formation as CL are larger
in size and in numbers in the rEDNRB-KO than wild type ovary
(Fig. 4). Or, the larger CL size may have nothing to do with CL forma-
tion process, but pertain to CL regression that this luteolytic process
may be delayed when EDNRB is absent. It was shown that PGF2α, a
trigger of luteolysis, initiate the luteolytic pathway by inducing
EDN1 synthesis in old CL (Boiti et al., 2007; Girsh and Dekel, 2002;
Girsh et al., 1996a, 1996b). While the endothelin receptor type that
is responsible for this CL regression pathway is not known, it would
be worth to see whether EDNRB is the EDN1 receptor for an initiating
the luteolytic pathway; loss of EDNRB may deter the luteolytic
pathway, leaving the CL live longer and keep it larger. Interestingly,
it was shown that luteolysis was inhibited by EDNRA antagonism
but not by EDNRB antagonist (Doerr et al., 2008; Keator et al., 2008;
Watanabe et al., 2006), indicating EDNRA plays as an initiator of
luteolysis. Therefore, further study is warranted to determine speciﬁc
endothelin-driven physiological events that are mediated by EDNRA
and EDNRB in regulating the luteolytic pathway.
Conclusion
Female rEDNRB-KO mice had larger litter sizes (numbers of pups
per birth) and their ovaries contained more corpus lutea than wild
type littermates. Therefore, EDNRB expression is not required for
ovulation, but may be necessary for terminating ovulation.
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